Restrictions on safety-net hospital access to 340B drug pricing program discounts have been a challenge for health system pharmacy leaders, with 16 drug companies imposing or announcing such constraints as of April 13.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,